Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × NIH × Dutasteride × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

OTHER 10 INDUSTRY 2 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Specimen Handling 142 Cyclophosphamide 140 Magnetic Resonance Spectroscopy 122 Biopsy 100 Radiotherapy 98 Bevacizumab 95 Cisplatin 91 Carboplatin 86 Doxorubicin 80 Paclitaxel 76 Etoposide 75 Filgrastim 72 Fluorouracil 67 aldesleukin 66 Gemcitabine 65 Vincristine 63 Leucovorin 57 fludarabine phosphate 50 Docetaxel 50 Bortezomib 47 Rituximab 44 Oxaliplatin 44 Sorafenib 43 Cytarabine 43 Irinotecan 39 sargramostim 38 Prednisone 38 Methotrexate 38 Immunoglobulin G 38 Disulfides 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01193855 2013-08-26

Dutasteride in Treating Patients With Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Unknown

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡